HomeProductsBuilding BlocksHeterocyclic ScaffoldsAromatic HeterocyclesRemibrutinib
Chemical structure of CAS 1787294-07-8

Remibrutinib

CAS No.1787294-07-8
MDL No.N/A
MFC27H27F2N5O3
MW507.50
InChI KeyCUABMPOJOBCXJI-UHFFFAOYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1787294-07-8
Product NameRemibrutinib

Associated Conditions

multiple sclerosis·liver disease·allergic disease·chronic idiopathic urticaria·immune system disease·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Novel Bruton's Tyrosine Kinase inhibitor remibrutinib: Drug-drug interaction potential as a victim of CYP3A4 inhibitors based on clinical data and PBPK modeling.

Clinical and translational science • Vol. 15, Issue 1 • 2022
PMID: 34432364PMC: PMC8742645DOI: 10.1111/cts.13126

Discovery of LOU064 (Remibrutinib), a Potent and Highly Selective Covalent Inhibitor of Bruton's Tyrosine Kinase.

Journal of medicinal chemistry • Vol. 63, Issue 10 • 2020
PMID: 32083858DOI: 10.1021/acs.jmedchem.9b01916

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Immunology • Vol. 160, Issue 1 • 2020
PMID: 32020584PMC: PMC7160657DOI: 10.1111/imm.13175

Documentation